Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudia Mazzarella

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 1, 2012
Predicting prostate biopsy outcome: prostate health index (phi) and prostate cancer antigen 3 (PCA3) are useful biomarkersMatteo Ferro, Dario Bruzzese, Sisto Perdonà, et al.
Plos One|July 18, 2013
Prostate Health Index (Phi) and Prostate Cancer Antigen 3 (PCA3) significantly improve prostate cancer detection at initial biopsy in a total PSA range of 2-10 ng/mlMatteo Ferro, Dario Bruzzese, Sisto Perdonà, et al.
The Prostate|July 24, 2012
Prostate health index (phi) and prostate cancer antigen 3 (PCA3) significantly improve diagnostic accuracy in patients undergoing prostate biopsySisto Perdonà, Dario Bruzzese, Matteo Ferro, et al.
Biosensors & Bioelectronics|February 21, 2016
Long period fiber grating nano-optrode for cancer biomarker detectionGiuseppe Quero, Marco Consales, Renato Severino, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 1, 2012
Predicting prostate biopsy outcome: prostate health index (phi) and prostate cancer antigen 3 (PCA3) are useful biomarkersMatteo Ferro, Dario Bruzzese, Sisto Perdonà, et al.
Plos One|July 18, 2013
Prostate Health Index (Phi) and Prostate Cancer Antigen 3 (PCA3) significantly improve prostate cancer detection at initial biopsy in a total PSA range of 2-10 ng/mlMatteo Ferro, Dario Bruzzese, Sisto Perdonà, et al.
The Prostate|July 24, 2012
Prostate health index (phi) and prostate cancer antigen 3 (PCA3) significantly improve diagnostic accuracy in patients undergoing prostate biopsySisto Perdonà, Dario Bruzzese, Matteo Ferro, et al.
Biosensors & Bioelectronics|February 21, 2016
Long period fiber grating nano-optrode for cancer biomarker detectionGiuseppe Quero, Marco Consales, Renato Severino, et al.
Pageof 3